Physician's Choice Clinical Trials
2 recruitingDrug
Phase 21Phase 31
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
HLA-A*0201 Positive Cells PresentClear Cell Sarcoma (CCS)
Sarcoma Alliance for Research through Collaboration47 enrolled2 locationsNCT06942442
Recruiting
Phase 3
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc.200 enrolled87 locationsNCT05948475